7.41k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies.
Curated by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies. These companies develop speciality drugs and treatments for various diseases and medical conditions. Although there are risks associated with the success of the drug, those that succeed tend to have a strong series of earnings growth over a period of time, especially when they are backed by patents.
The list includes stocks priced at $5 or more with a three-month average daily trading volume in excess of 200,000 shares. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.
This watchlist is similar to a discontinued watchlist called ‘Battling Cancer’.
Background
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the global financial markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.
How are these weighted?The stocks in this watchlist are weighted equally.
Watchlist | Change today | 1-month return | 1-year return | Total return |
---|---|---|---|---|
Biotech and drug stocks | -0.49% | - | - | - |
^GSPC | +0.11% | +3.10% | +30.45% | +5549.84% |
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly and Company | 777.96 | -0.22 | -0.03% | 16:00 GMT-4 | 3.19M | 3.24M | 739.66B |
NVO | Novo Nordisk A/S | 128.4 | +0.35 | +0.27% | 16:00 GMT-4 | 3.50M | 5.23M | 572.92B |
JNJ | Johnson & Johnson | 158.19 | +0.23 | +0.15% | 16:00 GMT-4 | 6.07M | 7.16M | 381.20B |
MRK | Merck & Co., Inc. | 131.95 | +0.20 | +0.15% | 16:00 GMT-4 | 10.13M | 8.81M | 334.18B |
ABBV | AbbVie Inc. | 182.1 | +1.75 | +0.97% | 16:00 GMT-4 | 5.40M | 5.71M | 322.44B |
AZN | AstraZeneca PLC | 67.75 | -0.51 | -0.75% | 16:00 GMT-4 | 3.42M | 6.34M | 210.05B |
RHHBY | Roche Holding AG | 31.92 | +0.61 | +1.95% | 16:00 GMT-4 | 1.77M | 1.83M | 205.51B |
NVS | Novartis AG | 96.73 | +0.85 | +0.89% | 16:00 GMT-4 | 1.51M | 1.45M | 197.72B |
PFE | Pfizer Inc. | 27.75 | -0.03 | -0.11% | 16:00 GMT-4 | 39.96M | 43.83M | 157.14B |
AMGN | Amgen Inc. | 284.32 | -1.98 | -0.69% | 16:00 GMT-4 | 2.28M | 3.04M | 152.37B |
SNY | Sanofi | 48.6 | -0.94 | -1.90% | 16:00 GMT-4 | 2.41M | 1.86M | 124.09B |
BMY | Bristol-Myers Squibb Company | 54.23 | +0.98 | +1.84% | 16:00 GMT-4 | 13.54M | 16.87M | 109.66B |
VRTX | Vertex Pharmaceuticals Incorporated | 418.01 | +0.69 | +0.17% | 16:00 GMT-4 | 1.05M | 1.32M | 107.98B |
REGN | Regeneron Pharmaceuticals, Inc. | 962.49 | -3.81 | -0.39% | 16:00 GMT-4 | 446.66k | 502.13k | 105.64B |
GILD | Gilead Sciences, Inc. | 73.25 | +0.24 | +0.33% | 16:00 GMT-4 | 8.24M | 7.61M | 91.25B |
GSK | GlaxoSmithKline plc | 42.87 | -0.12 | -0.28% | 16:00 GMT-4 | 1.85M | 3.57M | 87.98B |
ZTS | Zoetis Inc. | 169.21 | +0.70 | +0.42% | 16:00 GMT-4 | 3.34M | 2.74M | 77.48B |
TAK | Takeda Pharmaceutical Company Limited | 13.89 | -0.30 | -2.11% | 16:00 GMT-4 | 1.48M | 1.85M | 43.58B |
MRNA | Moderna, Inc. | 106.56 | -4.03 | -3.64% | 16:00 GMT-4 | 3.96M | 4.41M | 40.80B |
HLN | Haleon plc | 8.49 | -0.04 | -0.47% | 16:00 GMT-4 | 4.37M | 5.56M | 38.77B |
BIIB | Biogen Inc. | 215.63 | -0.71 | -0.33% | 16:00 GMT-4 | 1.76M | 1.18M | 31.34B |
BAYRY | Bayer Aktiengesellschaft | 7.66 | -0.01 | -0.13% | 15:59 GMT-4 | 3.57M | 1.77M | 30.24B |
ARGX | argenx SE | 393.72 | -4.87 | -1.22% | 16:00 GMT-4 | 184.20k | 349.80k | 23.35B |
BNTX | BioNTech SE | 92.25 | -0.72 | -0.77% | 16:00 GMT-4 | 432.99k | 692.25k | 21.93B |
GMAB | Genmab A/S | 29.91 | -0.72 | -2.35% | 16:00 GMT-4 | 355.48k | 642.34k | 19.71B |
ALPMY | Astellas Pharma Inc. | 10.75 | -0.19 | -1.74% | 15:59 GMT-4 | 295.56k | 251.19k | 19.27B |
ALNY | Alnylam Pharmaceuticals, Inc. | 149.45 | -4.94 | -3.20% | 16:00 GMT-4 | 554.94k | 869.85k | 18.82B |
RPRX | Royalty Pharma plc | 30.37 | -0.08 | -0.26% | 16:00 GMT-4 | 2.71M | 2.68M | 18.14B |
BGNE | BeiGene, Ltd. | 156.39 | +1.31 | +0.84% | 16:00 GMT-4 | 104.13k | 283.42k | 16.96B |
BMRN | BioMarin Pharmaceutical Inc. | 87.34 | -1.27 | -1.43% | 16:00 GMT-4 | 928.41k | 1.33M | 16.48B |
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy underperformed the Russell Midcap Growth Index and returned 13.66% (gross) and 13.44% (net) while the index return was -14.55%. In addition, please check […]
Gerresheimer CEO Dietmar Siemssen said he expects about 4% of the company's revenue growth per year from deals to supply makers of drugs for weight loss and diabetes with vials, cartridges, syringes and autoinjectors. Novo Nordisk's popular obesity drug Wegovy and Eli Lilly's in demand Zepbound are GLP-1 drugs. Siemssen said he expects sales related to GLP-1 medicines to surpass 100 million euros this year and to reach at least 350 million euros ($379 million) within the next three years, based on actual contracts and orders.
Analysts' stock picks include retail, consumer, and healthcare stocks.